Corrigendum to 'Deep molecular modeling and mechanistic insights into type 2A von Willebrand disease with von Willebrand factor A2 domain mutations': [Research and Practice in Thrombosis and Haemostasis 9(7) (2025) 103233]. [PDF]
Res Pract Thromb HaemostSeidizadeh O +7 more
europepmc +1 more source
Lung Microphysiological System Validates Novel Cell Therapy for Acute Respiratory Distress Syndrome
Advanced Biology, Volume 10, Issue 1, January 2026.This study aims to evaluate the efficacy of primed mesenchymal stem cells (pMSCs) as an alternative treatment for Acute Respiratory Distress Syndrome (ARDS), based on a novel lung microphysiological system (MPS) to test the efficacy of pMSCs over the standard treatment, Dexamethasone.
Bokyong Kim +11 more
wiley +1 more source
Genetic variants in VWF exon 26 and their implications for type 1 Von Willebrand disease in a Saudi Arabian population. [PDF]
Open Life SciAlzahrani FM +8 more
europepmc +1 more source
ROS‐Triggered Microgels for Programmable Drug Release in Volumetric Muscle Loss Repair
Advanced Healthcare Materials, Volume 15, Issue 3, 19 January 2026.Reduced graphene oxide‐incorporated hyaluronic acid microgels are developed as ROS‐responsive, injectable platforms for curcumin delivery in volumetric muscle loss. The microgels exhibit strong antioxidative activity, high drug‐loading capacity, and ROS‐triggered release.
Seungjun Lee +5 more
wiley +1 more source
Key residues regulating von Willebrand factor A1/A2 interactions: insights from molecular dynamics simulations and experimental validation. [PDF]
Res Pract Thromb HaemostFang J +5 more
europepmc +1 more source
Recombinant Proteins: A Molecular Tool to Understand Marine Adhesion and to Advance Biomaterials
Advanced Healthcare Materials, Volume 15, Issue 3, 19 January 2026.The production of recombinant proteins represents a fundamental step in the characterisation of marine invertebrate adhesives and in the development of bio‐inspired glues. The association of these proteins with other components such as ions, proteins, polysaccharides, or polymers enables the fabrication of biomaterials for various healthcare ...
Alessandra Whaite +4 more
wiley +1 more source
Current Challenges in Hemostasis and Advances in Particle‐Assisted Styptic Devices
Advanced Healthcare Materials, Volume 15, Issue 2, 14 January 2026.Here persistent limitations in hemostatic technologies are highlighted and cutting‐edge biomimetic, microparticle‐assisted, and nanoengineered systems with integrated drug delivery are showcased. Moreover, the article identifies fresh directions toward the next‐generation of multifunctional hemostatic devices with superior efficacy and accessibility ...
Daniele Baiocco +4 more
wiley +1 more source